Affinage

LOXHD1

Lipoxygenase homology domain-containing protein 1 · UniProt Q8IVV2

Length
2067 aa
Mass
235.7 kDa
Annotated
2026-06-10
26 papers in source corpus 8 papers cited in narrative 8 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LOXHD1 is a PLAT (polycystin/lipoxygenase/alpha-toxin) domain protein that localizes along the membrane of mature cochlear hair cell stereocilia and is required for auditory mechanotransduction rather than for stereociliary morphogenesis (PMID:19732867). Its function is developmentally gated: LOXHD1 is dispensable for hair bundle assembly and tip-link formation but becomes essential for inner hair cell mechanotransduction after the first postnatal week, coinciding with its postnatal stereociliary expression (PMID:19732867, PMID:33707295). Mechanistically, LOXHD1 maintains the pore-forming subunit TMC1 at the tip-link force-transmission site: in its absence the mechanotransduction machinery (including harmonin, LHFPL5, and intact tip links) is present but TMC1 mislocalizes away from the tip-link insertion point and currents are abolished (PMID:33707295, PMID:39256406). LOXHD1 interacts selectively in vitro with TMC1 but not its developmental paralogue TMC2, and binds the channel subunits CIB2 and LHFPL5 and the tip-link protein PCDH15, explaining why TMC2-driven developmental channels do not require LOXHD1 for tip-link coupling (PMID:39256406). Beyond the cochlea, the EWSR1::FLI1 oncofusion drives aberrant expression of a short LOXHD1 isoform via de novo enhancers, and this isoform supports Ewing sarcoma proliferation and invasion (PMID:35705030); LOXHD1 is also an immunogenic, surface-accessible antigen in Ewing sarcoma exploitable by TCR-engineered T cells (PMID:40234527).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2009 High

    Established that LOXHD1 is required for hair cell function and survival rather than for building the stereocilia, distinguishing a maintenance/activation role from a morphogenetic one.

    Evidence ENU-mutant samba mice with immunolocalization, hair cell physiology, and human family linkage

    PMID:19732867

    Open questions at the time
    • Molecular function of the PLAT domains not defined
    • No interacting partners identified
    • Mechanism of hair cell degeneration unresolved
  2. 2021 High

    Showed LOXHD1's requirement is developmentally gated to mechanotransduction after the first postnatal week, with the channel machinery present but non-activatable, narrowing its role to channel function rather than complex assembly.

    Evidence Two Loxhd1 knock-in mouse alleles (10th PLAT repeat), mechanotransduction current recording, immunolocalization of harmonin and LHFPL5

    PMID:33707295

    Open questions at the time
    • Did not identify which channel subunit LOXHD1 acts on
    • Direct binding partners not established
    • Mechanism by which channels become activatable unknown
  3. 2024 High

    Defined the molecular mechanism: LOXHD1 selectively retains TMC1 at the tip-link force-transmission site through direct interactions, explaining the paralogue-specific (TMC1 vs TMC2) and developmentally gated requirement.

    Evidence Mouse knockouts, SUB-immunogold-SEM for submembranous TMC1 localization, in vitro binding assays (TMC1, CIB2, LHFPL5, PCDH15)

    PMID:38260480 PMID:39256406

    Open questions at the time
    • Structural basis of selective TMC1 vs TMC2 binding not resolved
    • Stoichiometry and architecture of the LOXHD1-channel complex unknown
    • Whether LOXHD1 also gates the channel mechanically vs only localizing it is unresolved
  4. 2022 Medium

    Extended LOXHD1 biology beyond the cochlea by showing a short isoform is an EWSR1::FLI1 transcriptional output that promotes tumor proliferation and invasion in Ewing sarcoma.

    Evidence Integrative transcriptomics, enhancer deletion/silencing, proliferation and invasion assays in EwS cell lines

    PMID:35705030

    Open questions at the time
    • Molecular function of the short LOXHD1 isoform in tumor cells unknown
    • Whether the short isoform shares the stereociliary mechanism is unaddressed
    • Single-lab functional characterization
  5. 2012 Medium

    Linked LOXHD1 missense mutations to dominant late-onset Fuchs corneal dystrophy via a mutant-aggregation phenotype, implicating protein-protein interaction surfaces.

    Evidence NGS of FCD pedigree, corneal antibody staining, mutant allele expression aggregation assay, in silico modeling

    PMID:22341973

    Open questions at the time
    • Causal role in FCD contested by later systematic reviews
    • Aggregation mechanism not tied to a defined corneal function
    • Single-lab evidence
  6. 2025 Medium

    Demonstrated LOXHD1 is an immunogenic, surface-accessible antigen restricted to hair cells, testis, and Ewing sarcoma, enabling targeted T-cell killing of tumor cells.

    Evidence Proteomics/immunogenicity assays, TCR-engineered CD8+ T cells, in vitro cytotoxicity, mouse xenograft adoptive transfer

    PMID:40234527

    Open questions at the time
    • Topology/orientation explaining surface accessibility not directly resolved
    • On-target off-tumor risk in testis/cochlea not addressed
    • Single-lab study

Open questions

Synthesis pass · forward-looking unresolved questions
  • How LOXHD1's PLAT domains achieve selective TMC1 recognition and whether LOXHD1 contributes to channel gating beyond localization remains unresolved.
  • No high-resolution structure of LOXHD1 or its channel complex
  • Functional role of the short tumor isoform mechanistically uncharacterized
  • Membrane-binding mechanism of PLAT domains experimentally unvalidated

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008289 lipid binding 1 GO:0060090 molecular adaptor activity 1 GO:0140096 catalytic activity, acting on a protein 1
Localization
GO:0005886 plasma membrane 2 GO:0005856 cytoskeleton 1
Pathway
R-HSA-112316 Neuronal System 3 R-HSA-9709957 Sensory Perception 2

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2009 LOXHD1 consists entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains and is expressed along the membrane of mature hair cell stereocilia. In samba mice carrying an ENU-induced Loxhd1 mutation, stereociliary development is unaffected but hair cell function is perturbed and hair cells eventually degenerate, establishing LOXHD1 as required for hair cell function rather than stereociliary morphogenesis. ENU mutagenesis mouse model, immunolocalization, hair cell physiology, genetic linkage in human families American journal of human genetics High 19732867
2021 LOXHD1 is required for mechanotransduction in cochlear inner hair cells (IHCs), but only after the first postnatal week, coinciding with its postnatal expression/localization along the stereocilia. In two Loxhd1 mouse models bearing mutations in the 10th PLAT repeat, mechanotransduction currents in IHCs were severely reduced by postnatal day 11 without morphological defects to the hair bundle or reduction in tip-link number. Harmonin and LHFPL5 (upper and lower tip-link complex proteins) were maintained in their correct locations in the mutants, indicating that the mechanotransduction machinery is present but not activatable. Loxhd1 knock-in mouse models (two alleles), electrophysiology (mechanotransduction current recording), immunolocalization of tip-link complex proteins The Journal of neuroscience High 33707295
2024 LOXHD1 is essential for maintaining TMC1 (pore-forming subunit of mature auditory mechanosensitive channels) at the tip-link insertion site in stereocilia. Using SUB-immunogold-SEM, TMC1 was shown to localize within 100 nm of the tip link in wild-type mice but mislocalizes away from the force transmission site in the absence of LOXHD1. LOXHD1 selectively interacts in vitro with TMC1 (but not its developmental paralogue TMC2), and also binds channel subunits CIB2 and LHFPL5, and tip-link protein PCDH15. TMC2-driven developmental channels do not require LOXHD1 for tip-link coupling. Mouse knockout models, SUB-immunogold scanning electron microscopy (novel method for submembranous epitopes), in vitro binding assays (selective interaction of LOXHD1 with TMC1 but not TMC2), immunolocalization Nature communications High 39256406
2024 Preprint corroborating the peer-reviewed finding (PMID 39256406): LOXHD1 is indispensable for coupling TMC1-containing auditory mechanosensitive channels to the tip-link force transmission site; LOXHD1 interacts selectively with TMC1 but not TMC2 in vitro, and also binds CIB2, LHFPL5, and PCDH15. TMC1 is present but mislocalized in hair bundles lacking LOXHD1. Mouse models, SUB-immunogold-SEM, in vitro interaction assays Research square (preprint)preprint Medium 38260480
2012 Missense mutations in LOXHD1 cause dominant late-onset Fuchs corneal dystrophy (FCD). LOXHD1 protein is detected by antibody staining in human and mouse corneal epithelium and endothelium. Expression of familial and sporadic LOXHD1 mutant alleles in cultured cells produced prominent cytoplasmic protein aggregates, paralleling the punctate endothelial staining seen in corneas of patients with causal LOXHD1 mutations but absent in normal or mutation-negative FCD corneas. In silico analysis predicted mutations to reside on the protein surface and affect protein-protein interactions. Next-generation sequencing of FCD pedigree, antibody staining of human and mouse corneas, mutant allele expression in cell culture (aggregation assay), in silico structural modeling American journal of human genetics Medium 22341973
2016 Molecular modeling of the PLAT domain of LOXHD1 predicted that the missense mutation p.V1892F distorts the domain structure and would decrease the protein's affinity for the lipid membrane, consistent with a mechanism by which PLAT domain integrity is required for LOXHD1 membrane association and hair cell function. In silico 3D molecular modeling (SWISS-MODEL) of PLAT domain Auris, nasus, larynx Low 26973026
2022 In Ewing sarcoma, the oncofusion EWSR1::FLI1 transcription factor drives aberrant expression of a short LOXHD1 isoform via de novo enhancers upstream of an alternative transcription start site. Deletion or silencing of this EWSR1::FLI1-bound enhancer results in loss of the LOXHD1 short isoform, altered EWSR1::FLI1 and HIF1α pathway gene expression, and decreased proliferation and invasion of EwS cells. Integrative transcriptomic analysis, enhancer deletion/silencing, functional assays (proliferation, invasion) in EwS cell lines Cell reports Medium 35705030
2025 LOXHD1 protein expression is highly restricted to inner hair cells of the cochlea, adult testis, and Ewing sarcoma tumor cells. LOXHD1-specific TCR-engineered CD8+ T cells (targeting HLA-A*02:01-restricted LOXHD1 epitopes) conferred cytotoxic activity against HLA-A*02:01+ EwS tumor cell lines in vitro, and adoptive transfer led to tumor eradication in a mouse xenograft model of EwS, confirming surface/immunogenic protein expression in EwS. Proteomics/immunogenicity assays, TCR isolation, TCR-T cell engineering, in vitro cytotoxicity assay, mouse xenograft adoptive transfer Scientific reports Medium 40234527

Source papers

Stage 0 corpus · 26 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2012 Mutations in LOXHD1, a recessive-deafness locus, cause dominant late-onset Fuchs corneal dystrophy. American journal of human genetics 140 22341973
2009 Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans. American journal of human genetics 120 19732867
2011 A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews. American journal of medical genetics. Part A 34 21465660
2021 Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells. The Journal of neuroscience : the official journal of the Society for Neuroscience 33 33707295
2015 Mutations in LOXHD1 gene cause various types and severities of hearing loss. The Annals of otology, rhinology, and laryngology 29 25792669
2022 Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1. Cell reports 19 35705030
2019 Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort. Genes 18 31547530
2016 Analysis of SLC4A11, ZEB1, LOXHD1, COL8A2 and TCF4 gene sequences in a multi-generational family with late-onset Fuchs corneal dystrophy. International journal of molecular medicine 16 27121161
2023 Systematic review of SLC4A11, ZEB1, LOXHD1, and AGBL1 variants in the development of Fuchs' endothelial corneal dystrophy. Frontiers in medicine 14 37441688
2018 Analysis of candidate genes ZEB1 and LOXHD1 in late-onset Fuchs' endothelial corneal dystrophy in an Indian cohort. Ophthalmic genetics 14 29799290
2020 Five Novel Mutations in LOXHD1 Gene Were Identified to Cause Autosomal Recessive Nonsyndromic Hearing Loss in Four Chinese Families. BioMed research international 13 32149082
2024 LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission. Nature communications 12 39256406
2016 Clinical characteristics of a Japanese family with hearing loss accompanied by compound heterozygous mutations in LOXHD1. Auris, nasus, larynx 12 26973026
2021 Rising of LOXHD1 as a signature causative gene of down-sloping hearing loss in people in their teens and 20s. Journal of medical genetics 9 33753533
2019 A novel LOXHD1 variant in a Chinese couple with hearing loss. The Journal of international medical research 7 31709873
2021 Missense variant in LOXHD1 is associated with canine nonsyndromic hearing loss. Human genetics 6 33983508
2022 Genetic Analysis of the LOXHD1 Gene in Chinese Patients With Non-Syndromic Hearing Loss. Frontiers in genetics 3 35711932
2021 Recessive LOXHD1 variants cause a prelingual down-sloping hearing loss: genotype-phenotype correlation and three additional children with novel variants. International journal of pediatric otorhinolaryngology 3 33892339
2021 Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder. Otolaryngology case reports 3 35875410
2026 Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis care & research 2 40771159
2025 Clinical Exome Sequencing Identifies, Two Homozygous LOXHD1 Variants in Two Inbred Families With Pre-Lingual Hearing Loss From South India. Annals of human genetics 2 40070250
2020 Corrigendum to "Five Novel Mutations in LOXHD1 Gene Were Identified to Cause Autosomal Recessive Nonsyndromic Hearing Loss in Four Chinese Families". BioMed research international 2 33062705
2025 LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma. Scientific reports 1 40234527
2024 LOXHD1 is indispensable for coupling auditory mechanosensitive channels to the site of force transmission. Research square 1 38260480
2026 Identification of Novel LOXHD1 Variants in Chinese Patients with Non-Syndromic Hearing Loss. Journal of otology 0 42131115
2025 From Genes to Disease: Reassessing LOXHD1 and AGBL1's Contribution to Fuchs' Dystrophy. International journal of molecular sciences 0 40244234

Missed literature

Know a paper Affinage missed for LOXHD1? Flag it for the maintainers and the community.

No submissions yet.